{
  "ticker": "NDSN",
  "content": "**Report Generated:** January 23, 2026  \n**Next Refresh:** April 24, 2026\n\n**Disclaimer:** This sell-side report was generated using Claude Sonnet 4 (claude-sonnet-4-20250514). Please confirm all critical data independently, as AI models may hallucinate. These reports are for educational purposes only, and should not be solely used for investment decisions.\n\n---\n\n# Nordson Corporation (NDSN) - Comprehensive Analysis Report\n\n## 1. Company Overview\n\nNordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, medical components, and other fluids. The company was founded in 1909 and is headquartered in Westlake, Ohio. It operates through three segments: Industrial Precision Solutions; Medical and Fluid Solutions; and Advanced Technology Solutions.\n\nNordson Corporation, a multinational corporation headquartered in Westlake, Ohio, stands as a leader in precision dispensing, fluid management, and related technologies, operating in over 35 countries. From medical to food & beverage, Nordson has products and solutions for over 30 major industries. As of Jan 21, 2026, the company has ‪8 K‬ employees.\n\nThe company's business model is built on precision engineering solutions that enhance manufacturing efficiency while reducing material consumption. At its core, Nordson Corporation operates as an engineering and manufacturing powerhouse dedicated to solving complex industrial challenges. The company designs, produces, and markets a broad range of equipment, including pumps, valves, dispensers, applicators, filters, and pelletizers, that play a critical role in automating and optimizing material dispensing processes.\n\n## 2. Current Market Data\n\nThe Nordson Corporation stock price today is 237.63. Today Nordson Corporation has the market capitalization of ‪14.85 B‬, it has increased by 4.13% over the last week. NDSN stock has risen by 1.40% compared to the previous week, the month change is a 11.50% rise, over the last year Nordson Corporation has showed a 25.18% increase.\n\nYes, NDSN dividends are paid quarterly. The last dividend per share was 0.82 USD. As of today, Dividend Yield (TTM)% is 1.20%. Nordson Corporation dividend yield was 1.36% in 2025, and payout ratio reached 37.12%. The year before the numbers were 1.14% and 34.77% correspondingly.\n\nNordson Corporation EBITDA is ‪874.79 M‬ USD, and current EBITDA margin is 31.34%. The stock has fluctuated within a day range of 236.26 to 239.50, while its 52-week range spans from 165.03 to 251.47.\n\n## 3. Existing Products/Services\n\n### Industrial Precision Solutions (IPS)\nIndustrial Precision Solutions (IPS) serves traditional manufacturing with adhesive and coating systems. Hot melt machines and adhesive dispensing systems to apply adhesives, coatings, and sealants. Powder coating and liquid spray equipment for the automotive industry, electronics, container coating, and more applications.\n\n### Medical and Fluid Solutions (MFS)\nMedical and Fluid Solutions (MFS) provides fluid management components for medical devices and high-tech industrial applications. The Medical and Fluid Solutions segment offers precision manual and semi-automated dispensers, plastic molded syringes, cartridges, tips, and fluid connection components; interventional solutions for engineered shafts and interventional delivery systems, medical tubing, balloons, balloon inflators, nitinol devices, cardiovascular cannula, and biomaterial delivery; medical fluid components; and microplegia myocardial protection devices and related consumables.\n\n### Advanced Technology Solutions (ATS)\nAdvanced Technology Solutions (ATS) focuses on electronics assembly and test/inspection equipment. The Advanced Technology Solutions segment provides automated dispensing systems for high-speed, precise application of various attachment, protection, and coating fluids, and related gas plasma treatment systems; destructive and non-destructive testing technologies, such as bond testers and automated optical, acoustic microscopy, and x-ray inspection systems used in the semiconductor and printed circuit board industries; and precision measurement and control technologies.\n\nApplications include, but are not limited to, semiconductors, printed circuit boards, electronic components, and automotive electronics. Precision fluid dispensing, plasma treatment, selective soldering, and conformal coating of printed circuit boards.\n\n## 4. Planned Products/Services/Projects\n\nShanghai, China – November 12, 2025 – Nordson is excited to announce the launch the launch of Presto™, a purpose-built... Ready for Every Stretch: Nordson Introduces Presto™ Nozzle for Super-Fine Elastic Applications in Hygiene Production\n\nA: Sundaram Nagarajan, President, CEO: AI is evolving, and we are bullish on its value. We have early-stage ideas for using AI to enhance our products' effectiveness. While AI adoption is in early stages, we are excited about its potential in our X-ray business and other areas.\n\nNordson Electronics Solutions to demonstrate automated fluid dispensing and selective soldering systems for electronics manufacturing at productronica 2025\n\n## 5. Growth Strategy\n\nNordson is executing a deliberate portfolio upgrade through its Ascend strategy, acquiring Atrion's high-margin medical consumables while divesting lower-growth contract manufacturing, creating a more resilient, higher-quality earnings stream positioned for secular growth in medical and electronics. The Advanced Technology Solutions segment has emerged as a genuine growth engine, delivering consecutive quarters of double-digit organic growth driven by semiconductor backend demand, while the Industrial Precision Solutions segment appears to have bottomed despite cyclical headwinds in polymer processing. The NBS Next operational framework is proving its worth through superior acquisition integration (Atrion became EPS accretive a year ahead of schedule) and margin resilience, enabling record free cash flow conversion of 180% even amid mixed market conditions.\n\nThe implementation of the Ascend Strategy, a combination of our NBS Next growth framework, owner mindset and winning teams, positions us well to meet increasing customer demand. We also remain focused on creating value for our shareholders by deploying strategic capital for acquisitions, share repurchases, dividends and debt service.\n\nSundaram Nagarajan, President and Chief Executive Officer, said, \"Nordson's success has been driven by its customer-centric business model, commitment to innovation and end market diversification. Over the past two years, we've added to these strengths through the deployment of the NBS Next growth framework, which gives us a clear view of our greatest growth opportunities.\n\n## 6. Current and Potential Major Clients\n\nThe Company's direct sales model and applications expertise serves global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets.\n\nProducts and applications using LED lights include aviation lighting, vehicle and truck lighting, signs, flash lights, traffic signals, solar lamps, appliance lighting and home lighting.\n\nA: Sundaram Nagarajan, President and CEO: The strength remains in semiconductor applications for AI and cloud computing. Automotive is stabilizing, and general electronics has been decent, though with lower growth compared to semiconductors. About 50% of revenues come from semiconductors, 15% from automotive, and the rest from electronics.\n\n## 7. Financial Data & Performance\n\n### Fiscal Year 2025 Results (ended October 31, 2025)\nNordson Corp (NASDAQ:NDSN) achieved record sales of $2.8 billion in fiscal 2025, marking a 4% increase from the previous year. The company reported a 9% growth in adjusted earnings per share, reaching the high end of their fourth-quarter guidance.\n\n### Fourth Quarter 2025\nSales were $752 million, a 1% increase compared to the prior year's fourth quarter sales of $744 million. Net income was $152 million, or earnings per diluted share of $2.69, compared to prior year's fourth quarter net income of $122 million, or earnings per diluted share of $2.12. Adjusted net income was $171 million, up from prior year adjusted net income of $160 million.\n\nNordson Corp (NASDAQ:NDSN) generated record EBITDA of $256 million in the fourth quarter, with an EBITDA margin expansion to 34%. EBITDA: $256 million, representing 34% of sales, a 160 basis point improvement.\n\n### Full Year 2025\nFull Year Adjusted EPS: $10.24, exceeding the midpoint of initial guidance. Full Year EBITDA: $900 million, achieving the Ascend Strategy goal. Free Cash Flow Conversion: 136% of net income for the full year. Net Debt: Reduced to a leverage ratio of 2.1 times.\n\n### Fiscal 2026 Guidance\nManagement expects full-year sales to come in between 1% and 6% above fiscal 2025 levels. For fiscal 2026, the company forecast adjusted earnings growth of 6% to 12% per diluted share, with a midpoint of 9%. For the first quarter, Nordson expects sales in the range of $630 million to $670 million and adjusted earnings between $2.25 and $2.45 per diluted share.\n\n## 8. Headwinds & Tailwinds\n\n### Tailwinds:\n• **Strong Electronics Demand**: The Advanced Technology Solutions segment has emerged as a genuine growth engine, delivering consecutive quarters of double-digit organic growth driven by semiconductor backend demand. The Advanced Technology Solutions segment's emergence as a double-digit growth engine, powered by semiconductor backend demand and share gains in electronics dispensing, provides a compelling growth vector that differentiates Nordson from traditional industrial peers.\n\n• **Strategic Portfolio Optimization**: Meanwhile, the successful integration of Atrion and the divestiture of lower-margin contract manufacturing are reshaping the Medical and Fluid Solutions segment into a higher-quality, more focused business with recurring consumables revenue.\n\n• **Operational Excellence**: In ATS, it helped deliver 27% EBITDA margins during the recent down cycle by optimizing manufacturing footprint and reducing costs. In MFS, it facilitated Atrion's rapid integration and synergy realization. This operational excellence is not merely cost-cutting; it is a competitive advantage that allows Nordson to maintain investment in R&D and customer support while peers may be forced to retrench.\n\n### Headwinds:\n• **Industrial Market Weakness**: Also, supply-chain constraints, particularly in the medical device business, remain a concern for the company. The escalating costs and expenses have also been a major concern for the company. In the fiscal fourth quarter, its cost of sales recorded a year-over-year increase of 1.9%. Also, in the same quarter, the company's selling and administrative expenses increased 12.5% year over year due to high acquisition costs.\n\n• **Cyclical Demand Issues**: The Industrial Precision Solutions segment experienced a 2% decrease in sales, with declines in polymer processing and industrial coating systems. Nordson Corp (NASDAQ:NDSN) faced challenges in the automotive-related systems and selected X-ray Inspection applications, impacting organic sales. The company anticipates only modest growth in the first quarter of fiscal 2026, with sales forecasted to be in the range of $630 million to $670 million.\n\n• **Competition and Scale Disadvantage**: Scale disadvantage relative to larger industrial conglomerates presents a structural vulnerability. Illinois Tool Works (ITW) and Dover (DOV) have enterprise values of $80.7 billion and $26.9 billion respectively, compared to Nordson's $15.5 billion. Their greater scale provides purchasing power, broader distribution, and the ability to bundle products across divisions.\n\n## 9. Market Shares\n\nThe Industrial Precision Solutions segment is Nordson's largest revenue contributor, representing 55% of total sales in fiscal Q1 2025. The Medical and Fluid Solutions segment is a key growth driver, with sales increasing by 21% in fiscal Q1 2025, bolstered by strategic acquisitions. Advanced Technology Solutions accounts for 19% of Nordson's revenue in fiscal Q1 2025.\n\nIPS represents approximately 47% of year-to-date sales, making it the largest segment and a significant driver of consolidated performance.\n\n## 10. Comparison to Competitors\n\nKey direct competitors frequently identified include Graco, Lincoln Electric, Donaldson, Dover, IDEX, ITT, Illinois Tool Works, Parker-Hannifin, and Pentair. Additionally, other significant players in specific market niches are Carlisle Companies, Oerlikon Balzers, Langley Holdings, SAMES, Dymax, and Valco Melton.\n\nFlowserve, Parker-Hannifin, Dover (Machinery (B2B)), Graco, and AMETEK are some of the 30 competitors of Nordson.\n\nNordson's competitive moat rests on proprietary precision technology that delivers measurable economic benefits to customers. The company's jetting systems can dispense fluids with accuracy measured in microns, reducing material waste and increasing line speeds for customers in packaging, electronics, and medical device manufacturing.\n\n## 11. Partnerships, Mergers and Acquisitions\n\n### Recent Major Acquisitions:\n\n**ARAG Group (June 2023)**: Nordson Corporation (Nasdaq: NDSN) today announced that it has entered into a definitive agreement to acquire ARAG Group and its subsidiaries (\"ARAG\") in an all-cash transaction that values ARAG at an enterprise value of €960 million. Headquartered in Rubiera, Italy, ARAG is a global market and innovation leader in the development, production and supply of precision control systems and smart fluid components for agricultural spraying. Its portfolio consists of three key product families: fluid components, such as nozzles, pumps and filters; smart components that measure and control the flow, quantity and location of the dispensed fluid; and control systems that provide a greater variety of input and functionality to the customer.\n\n**Atrion Corporation (August 2024)**: The Atrion acquisition has performed above expectations, contributing significantly to growth and becoming EPS accretive a year ahead of schedule. Nordson acquired Atrion Corporation in August 2024. The inclusion of Atrion's three major businesses — Halkey Roberts, Atrion Medical and Quest Medical — will enable NDSN to expand its medical offerings in the infusion and cardiovascular therapies market. Management expects the buyout to offer significant operational synergies when combined with its medical business expertise.\n\n**NDC Technologies**: Nordson Corp has announced the acquisition of NDC Technologies from Spectris plc for $180 million in cash.\n\n### Divestitures:\nNordson Corporation (Nasdaq: NDSN) has completed the divestiture of select product lines within its medical contract manufacturing business to Quasar Medical. \"This divestiture allows Nordson MEDICAL to focus on its higher value growth opportunities within our $800 million medical and fluid solutions segment.\n\n## 12. Recent Developments\n\n• **Record Q4 2025 Results**: Sales were up 1% over prior year, inclusive of the divestiture of our medical contract manufacturing business that closed on September 2. Adjusted earnings per share grew 9% over the prior year, reaching the high end of our fourth quarter guidance.\n\n• **Strong Cash Generation**: We also generated record cash flow of $194 million in the quarter, which is a conversion rate to the net income of 128%. This enabled us to continue repurchasing shares, paying dividends, and further reducing debt.\n\n• **Dividend Increase**: In August 2024, the company hiked its dividend by 15% to 78 cents per share. This marks its 61st consecutive year of dividend increase.\n\n• **Share Repurchases**: Year-to-date share repurchases of $212 million, with $800 million in remaining authorization, demonstrate management's confidence in value creation.\n\n## 13. AI Investment Rating & Fair Value Assessment\n\n### Analyst Consensus:\nThe 6 analysts that cover Nordson stock have a consensus rating of \"Strong Buy\" and an average price target of $261.67, which forecasts a 19.64% increase in the stock price over the next year. Based on analyst ratings, Nordson Corp's 12-month average price target is 260.40. Nordson Corp has 12.94% upside potential, based on the analysts' average price target.\n\n### Recent Analyst Updates:\n12/11/2025 – Nordson had its price target raised by analysts at KeyCorp from $250.00 to $295.00. They now have an \"overweight\" rating on the stock. A few days earlier, on December 12, DA Davidson raised its price target on Nordson to $290 from $285 and kept a Buy rating after the company delivered a Q4 earnings beat. The firm pointed to improving operating margins, especially in the Medical and Fluid Solutions segment, where divestiture benefits and volume recovery are starting to show. Order activity within Advanced Technology Solutions also looks healthy, based on recent inbound trends. DA Davidson added that the company's balance sheet remains strong, leaving room for additional share buybacks.\n\n### Investment Assessment:\n\n**Strengths:**\n• Strong execution of Ascend strategy with portfolio optimization\n• Exceptional cash flow generation (136% of net income conversion)\n• Market-leading positions in precision dispensing technology\n• Diversified end markets with secular growth drivers\n• 62 consecutive years of dividend increases\n\n**Risks:**\n• Cyclical exposure to industrial markets\n• Scale disadvantage versus larger competitors\n• Integration risks from acquisitions\n• Rising operational costs and expenses\n\n**AI Investment Rating: 7.8/10**\n\n**Rationale:** Nordson demonstrates strong strategic execution with its Ascend strategy, delivering consistent cash flow generation and successful acquisition integration. The company's transformation into higher-margin, secular growth markets (medical devices, semiconductor packaging) positions it well for long-term value creation. While facing near-term cyclical headwinds in industrial markets, the diversification and operational excellence provide downside protection.\n\n**Fair Value Estimate: $275-285**\n\nBased on: \n- Analyst consensus of $261-295 range\n- Strong EBITDA margins (31%+) and cash conversion\n- Successful portfolio transformation execution  \n- Premium valuation justified by quality and consistency\n- Current price around $237 offers attractive entry point for long-term growth-oriented investors\n\nThe stock represents a compelling opportunity for investors seeking exposure to precision technology with strong defensive characteristics and secular growth drivers in medical and electronics end markets.",
  "generated_date": "2026-01-23T08:01:11.213892",
  "next_refresh_date": "2026-04-24T08:01:11.213892",
  "model": "claude-sonnet-4-20250514",
  "cost": 0.4666899,
  "tokens": {
    "input": 203,
    "output": 6062,
    "cache_creation": 74380,
    "cache_read": 320753
  },
  "tldr_summary": "Nordson Corporation is a precision engineering company that designs and manufactures advanced fluid dispensing, coating, and control systems for industries ranging from medical devices to electronics and manufacturing.\n\nThe company is executing a strategic transformation through its Ascend strategy, focusing on high-growth segments like semiconductor and medical technologies while divesting lower-margin businesses. Key strengths include market leadership in precision fluid technologies, consistent cash flow generation, and successful strategic acquisitions like Atrion. The Advanced Technology Solutions segment is driving growth through semiconductor and electronics demand, while the company maintains a diversified portfolio across multiple industrial sectors. Recent developments include record cash flow, 62 consecutive years of dividend increases, and strategic portfolio optimization.\n\nWith a strong analyst consensus, an AI investment rating of 7.8/10, and a fair value estimate of $275-285, Nordson represents an attractive investment opportunity in precision technology with stable, growth-oriented characteristics."
}